|
|
Volumn 8, Issue 12, 2013, Pages
|
|
Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy Number
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALK PROTEIN;
AMINOTRANSFERASE;
CRIZOTINIB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
MEMBRANE PROTEIN;
ROS1 PROTEIN;
SCATTER FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
ANAPLASTIC LYMPHOMA KINASE;
ANTINEOPLASTIC AGENT;
DNA;
EGFR PROTEIN, HUMAN;
MET PROTEIN, HUMAN;
ONCOPROTEIN;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
PYRAZOLE DERIVATIVE;
PYRIDINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
ROS1 PROTEIN, HUMAN;
AGED;
BRAIN METASTASIS;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
FINE NEEDLE ASPIRATION BIOPSY;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE DOSAGE;
GENE MUTATION;
HUMAN;
IMAGE ANALYSIS;
LUNG ADENOCARCINOMA;
PLEURA DISEASE;
PRIORITY JOURNAL;
RASH;
SEQUENCE ANALYSIS;
SHORT SURVEY;
TREATMENT OUTCOME;
ADENOCARCINOMA;
DRUG EFFECTS;
DRUG RESISTANCE;
GENETICS;
LUNG NEOPLASMS;
MUTATION;
PATHOLOGY;
PROGNOSIS;
SALVAGE THERAPY;
ADENOCARCINOMA;
AGED;
ANTINEOPLASTIC AGENTS;
DNA, NEOPLASM;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
GENE DOSAGE;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
LUNG NEOPLASMS;
MUTATION;
PROGNOSIS;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-MET;
PYRAZOLES;
PYRIDINES;
QUINAZOLINES;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
SALVAGE THERAPY;
|
|
EID: 84892167169
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1097/JTO.0b013e3182a00e37 Document Type: Article |
|
Times cited : (14)
|
|
References (3)
|
